Schenkein David P bought PRME
June 5, 2026 · Form 4 insider transaction
Schenkein David P bought 75,000 shares of Prime Medicine, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 3 days after the transaction.
Direction
Acquired (buy-side)
Shares
75,000
Price
$0.00
Total value
N/A
InsiderSchenkein David P
Role—
CompanyPrime Medicine, Inc. (PRME)
SecurityStock Option (right to buy)
Transaction codeA: Grant or award
Transaction dateJune 5, 2026
Filing dateJune 8, 2026
Shares owned after75,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The shares subject to this option shall vest in full upon the earlier of (i) June 5, 2027 or (ii) the date of the next annual meeting of stockholders, subject to the Reporting Person's continuous service to the Issuer through such vesting date.